Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - Annual European Congress of Rheumatology (EULAR)
Potential Sequence of TNF Inhibitors in Rheumatoid Arthritis and Evidence for Staying in Class Before Switching Mechanisms
Berlin, Germany / June 6-9, 2012
Berlin - Approximately 30% of patients with rheumatoid arthritis (RA) treated with a tumour necrosis factor (TNF) inhibitor will not have an adequate response. However, inadequate response on one of these agents does not predict failure on...
PRIORITY PRESS - 89th Annual Meeting of the Canadian Paediatric Society
Prevention and Minimization of Potential Complications from Infection and Disorders in Infancy
London, Ontario / June 6-9, 2012
London, Ontario - Vaccination is the premier strategy recommended for preventing common and rare childhood infections and its track record is exceedingly impressive. Yet as delegates heard during the CPS meeting, there appears to be a...
PRIORITY PRESS - 89th Annual Meeting of the Canadian Paediatric Society
Addressing Public Perception of Vaccination
London, Ontario / June 6-9, 2012
London, Ontario - Public distrust in vaccines appears to be increasing, fuelled by factors that include anti-vaccination voices throughout the Internet. A recent survey of Canadian parents showed that while the majority do have their...
MEDICAL FRONTIERS - 2012 Annual European Congress of Rheumatology (EULAR)
Oral Biologics Gain Attention as Safety Data Catch Up with Efficacy Data in Rheumatoid Arthritis Control
Berlin, Germany / June 6-9, 2012
Berlin - The potential to target the inflammatory cascade with oral rather than injectable targeted therapies in rheumatoid arthritis (RA) remains strong, based on studies evaluating agents with different mechanisms that were presented at...
PRIORITY PRESS - 2012 Annual European Congress of Rheumatology (EULAR)
Progress in Oral Biologics for Rheumatoid Arthritis
Berlin, Germany / June 6-9, 2012
Berlin - Oral therapies for rheumatoid arthritis that target very specific molecular steps in the inflammatory pathway have reached phase III trials. The data generated from these trials indicate that the anti-inflammatory activity of...
PRIORITY PRESS - 28th CINP World Congress of Neuropsychopharmacology
Resetting the Internal Master Clock: A Novel Approach to the Treatment of Depression
Stockholm, Sweden / June 3-7, 2012
Stockholm - It has long been argued that human health and well-being are tied to synchronization of circadian rhythms. This is particularly relevant in depressive patients in whom circadian rhythms are often profoundly disrupted. This...
PRIORITY PRESS - 28th CINP World Congress of Neuropsychopharmacology
Novel Atypical Antipsychotic Seeks Balanced Control of Symptom Complexes
Stockholm, Sweden / June 3-7, 2012
Stockholm - Improved control of both positive and negative symptoms in schizophrenia was one of the defining advances of atypical vs. typical antipsychotic agents. In bipolar disease, the most effective atypicals are those that control both...
MEDICAL FRONTIERS - American Transplant Congress
Evaluating Strategies to Extend and Maximize Patient and Graft Survival
Boston, Massachusetts / June 2-6, 2012
Boston - For initial maintenance therapy following transplantation, guidelines recommend first-line use of calcineurin inhibitors (CNIs) with an antiproliferative agent, with or without steroids. However, experts now strive to achieve...
PRIORITY PRESS - 48th Annual Meeting of the American Society of Clinical Oncology
Targeting Androgen Signalling in Metastatic Castration-resistant Prostate Cancer
Chicago, Illinois / June 1-5, 2012
Chicago - Improved understanding of the mechanisms of castration-resistant prostate cancer (CRPC) has led to the recognition of the key role the androgen receptor (AR) has in disease progression. Accumulating evidence suggests that AR...